Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home
 
Publications
Front. Immunol.: Longet S. and Paul S. https://www.frontiersin.org/articles/10.3389/fimmu.2023.1216402/full
Vindry C, Guillin O, Wolff P, Marie P, Mortreux F, Mangeot PE, Ohlmann T, Chavatte L. Nucleic Acids Res. 2023 May 31:gkad482. doi: 10.1093/nar/gkad482.
Proof-of-Concept Human Organ-on-Chip Study: First Step of Platform to Assess Neuro-Immunological Communication Involved in Inflammatory Bowel Diseases Int. J. Mol. Sci.: Gabriel-Segard T., Rontard J., Miny L., Dubuisson L., Batut A., Debis D., Gleyzes M., François F., Larramendy F., Soriano A., Honegger T. and Paul S. https://www.mdpi.com/1422-0067/24/13/10568
Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations Clinical Microbiology Reviews: Miguelena Chamorro B., De Luca K., Swaminathan G., Longet S., Mundt E., Paul S. https://journals.asm.org/doi/10.1128/cmr.00164-22
Vaccines: Miguelena Chamorro B., De Luca K., Swaminathan G., Rochereau N., Majorel J., Poulet H. Chanut B., Piney L., Mundt E., Paul S. https://www.mdpi.com/2076-393X/11/5/982
Legrand AF, Lucifora J, Lacombe B, Ménard C, Michelet M, Foca A, Abrial P, Salvetti A, Rivoire M, Lotteau V, Durantel D, André P, Ramière C. Hepatol Commun. 2023 Apr 14;7(5):e0078.
 
Actualités
Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.
CERP - Genomic information from Coronaviruses, like SARS-CoV-2, can be used to track the genetic evolution of the virus and study the correlation of new variants with the emergence of epidemiological waves. We developed a simple Machine Learning algorithm to define emerging variants in terms of clusters, based only on the spike protein information.
New publication - VIV Team in Nature communication
The planned appointment date will be halfway of 2022-2026, in order to prepare the candidate to take over the management of the Institute starting on 1st January 2027 for a first five-year term. The date of integration into the Institute, ideally mid-2024, should allow a strong involvement in the establishment of the preparation of the CIRI next term project and a transition period with the present Director, François-Loïc Cosset.
Nous rejoindre
CERP - Genomic information from Coronaviruses, like SARS-CoV-2, can be used to track the genetic evolution of the virus and study the correlation of new variants with the emergence of epidemiological waves. We developed a simple Machine Learning algorithm to define emerging variants in terms of clusters, based only on the spike protein information.
The planned appointment date will be halfway of 2022-2026, in order to prepare the candidate to take over the management of the Institute starting on 1st January 2027 for a first five-year term. The date of integration into the Institute, ideally mid-2024, should allow a strong involvement in the establishment of the preparation of the CIRI next term project and a transition period with the present Director, François-Loïc Cosset.
CERP - This will be a senior position at the recently created Center of Excellence in Respiratory Pathogens (CERP, https://ciri.ens-lyon.fr/cerp ) based in Lyon, France. The CERP develops evidence generating research to support decision making related to respiratory pathogens within the Civil Hospitals and the University Claude Bernard in Lyon. (...)
A 2-year post-doctoral position for a highly motivated and talented postdoctoral fellow is available in the team of Dr Marc Vocanson at the Centre International de Recherche en Infectiologie (CIRI), in Lyon, France.
Le candidat retenu travaillera dans le cadre d'un projet collaboratif JPIAMR DRUID (NOBACT) financé par l'ANR et portant sur l’évaluation de l’activité d’un nouvel antibiotique inhibiteur de CopA, une ATPase de type P transportant le cuivre, et identifier son impact sur la physiologie bactérienne.
A post-doctoral position in Immuno-Therapy is open in EVIR Team
Agenda
" The origins of HIV-1 through the lens of host-virus interactions "
"Yersinia species as model bacteria to study host/pathogen interactions & evolution"
"The sources of antigenic peptides for the MHC class I pathway"
"Decoding the battle between Mycobacterium tuberculosis and host metal defenses"
" Scientific publishing at JEM: What, How and Why? "
"Type I interferon exhaustion"